[Hybrid] China’s Transition through COVID and its Economic Recovery Go back »
-
Time2023-02-20 | 16:00 - 17:30
-
Venue:Zoom/European Chamber Office Beijing, Room C405
-
Address:
-
Fee:Members: 200 |
Non Members: 400
Speakers
Mr. Jörg Wuttke
Jörg Wuttke is Chief Representative of BASF China, based in Beijing. Wuttke is President of the EU Chamber of Commerce in China – an office he already held from 2007 to 2010 and from 2014 to 2017. Wuttke is a member of the Advisory Board of the Mercator Institute for China Studies (MERICS) in Berlin. He contributes regularly to the Swiss financial blog https://themarket.ch/. Wuttke has lived in Beijing for more than three decades.
Mr. Rodney Jones
Rodney Jones is the Principal of Wigram Capital Advisors, one of the earliest Asian-focused macro advisory firms, which he established in Hong Kong in 2001. Wigram provides economic analysis and advice on developments in Asia to global investors and selected government policy makers.
Rodney has been working as an economist and analyst in Asia for more than 30 years, having lived in Asia for 25 of those years. Rodney was resident in Beijing from 2010 to 2019. Prior to establishing Wigram, Rodney was a Managing Director and Partner with Soros Fund Management, heading up the research office in Hong Kong from 1994-2000, having started working as an economist in Singapore in 1990.
In recent years, Wigram has established a strong data science focus. Rodney and the team provided modelling on the path of the COVID-19 pandemic to the New Zealand government from early 2020. He is a graduate of the University of Auckland, New Zealand. In 2021 Rodney was awarded a MNZM for his contribution to economics and New Zealand’s COVID-19 strategy.
Dr. Bernhard Schwartländer
Dr. Bernhard Schwartländer, Global Health Envoy, the German Ministry of Foreign Affairs, also the former Chef de Cabinet of Dr Tedros Adhanom Ghebreyesus, Director General of the WHO, is a medical doctor and holds a doctorate in medical epidemiology. He received his education and professional training in Germany and the US at the Centers for Disease Control and Prevention. He use to be the WHO Representative in China. Before joining WHO in China, he served as Director for Evidence, Policy, and Innovation at UNAIDS headquarters in Geneva and as the United Nations Country Coordinator on AIDS in Beijing, China. Prior to these assignments, Dr. Schwartländer held a number of senior international positions including the Director for Performance Evaluation and Policy at the Global Fund to Fight AIDS, Tuberculosis, and Malaria; Director of the World Health Organization’s HIV Department; and as the Director of Evaluation and Strategic Information at UNAIDS.
In 2000, Dr. Schwartländer undertook a special assignment at the World Bank to perform economic analyses on the cost and impact of the HIV/AIDS epidemic and the responses to it. Prior to joining the United Nations, Dr. Schwartländer was the Director of the national AIDS program in Germany and the Director of the Division of Infectious Disease Epidemiology at the Robert Koch-Institute in Berlin, the central biomedical and infectious disease research and reference laboratory of the federal Ministry of Health, Germany.
Dr. Schwartländer has published widely in scientific journals and books and taught applied epidemiology in Berlin. He brings extensive experience in development policies as well as infectious disease epidemiology and programming at global and country levels.
Mr. Wei He
Wei He tracks Chinese monetary and fiscal policy for Gavekal Dragonomics. He previously worked at Financial Times Confidential, where he wrote on a wide range of macroeconomic and financial topics, as well as Market News International. A Beijinger, he has a BA in finance from Peking University, and an MA in politics from New York University.